Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Visual Hallucinations: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Visual Hallucinations: 1 US clinical trial tracked, none currently recruiting.

Visual Hallucinations is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Axovant Sciences, running 1 of these trials.

Enrollment posture brief

Registry condition visual-hallucinations

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Visual Hallucinations (this)0%
Open-enrollment share among volume-matched conditions near Visual Hallucinations

Visual Hallucinations has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Visual Hallucinations on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Visual Hallucinations is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Axovant Sciences 1 trials

Named interventions

Most-linked intervention names on Visual Hallucinations records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Nelotanserin Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Visual Hallucinations trials. A trial with sites in several states counts in each.

Texas 1 trials
Ohio 1 trials
Nebraska 1 trials
North Carolina 1 trials
Minnesota 1 trials
Kansas 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Visual Hallucinations page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Visual Hallucinations trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Axovant Sciences sponsors the most Visual Hallucinations trials on record, review their full trial history before evaluating a specific study. See Axovant Sciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Visual Hallucinations condition card totals 1 registered trials; most-linked intervention Nelotanserin; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.